DAXOR CORP

DAXOR CORP (DXR) is a publicly listed company on US equity markets.

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.

The company reports trailing twelve-month revenue of $1.45M and net loss of $7.19M.

Key metrics include a return on equity of -19.8%, a debt-to-equity ratio of 1.37.

Use FINOTAUR to track DXR's price action, review fundamentals, and stay current with company news — all in one research dashboard.